The primary cause of this study is to investigate the changes that ALL may cause to the metabolome of pediatric patients, in order to better understand its mechanism of action and target metabolic pathways for potential therapies.
Age
0–16
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Sex: all
Minimum age: 1 year
Maximum age: 16 years
The study accepts healthy volunteers as matched controls for the patinets.
You may not be if
Population description: Patients are recruited from the Pediatric Hematology/Oncology Department of Aristotle University of Thessaloniki (AHEPA hospital) and from the Pediatric Hematology/ Oncology Department of Ippokration Hospital, that host all children diagnosed with ALL in nothern Greece. Matched controls are recruited from outpatient clinic of the 2nd and 4th Pediatric Department of Aristotle University of Thessaloniki.